Search Results 1671-1680 of 18797 for Relapse

  1. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.

  3. Postpartum depression - Diagnosis and treatment - Mayo Clinic

    Stopping treatment too early may lead to a relapse. Postpartum psychosis. Postpartum psychosis requires immediate treatment, usually in the hospital ...

  4. Study Of Efficacy And Safety Of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With Or Without Ribavirin For Participants With Hepatitis C Genotype 1, 4, Or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    Previous HCV treatment status of peginterferon/RBV Null responder; or peginterferon/RBV Partial responder; or peginterferon/RBV Treatment Relapse; For human ...

  5. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    ... relapsed or become refractory to conventional therapy; Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) ...

  6. Publications - David C. Fipps, D.O. - Mayo Clinic

    ... Relapse, and Outcomes in Liver Transplantation: A Retrospective Cohort Study. J Acad Consult Liaison Psychiatry. 2024 Nov-Dec; 65 (6):537-544 Epub 2024 June ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  8. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment - Mayo Clinic

    Subjects who have had a HSCT and who experience relapse or progression of the malignancy as per investigator's opinion are not to be enrolled. Undergoing ...

  9. Oncology (Medical) - Clinical trials

    ... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study ...

  10. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...